Circulars
Circular No. 2022-004-A
Amendment to FDA Circular No. 2022-004 entitled "Implementing Guidelines on the Abridged and Verification Review Pathways for New Drug Registration Applications in accordance with Administrative Order No. 2020-0045 Establishing Facilitated Registration Pathways for Drug Products including Vaccines and Biologicals" to include Generic Drug Registration Applications and update the list of Reference Drug Regulatory Agencies
- Date issued
- 2023-02-15
- Date filed
- 2023-02-16
- Registration number
- 24-00195
Document
Official copy
Electronic copy filed with ONAR.
If this file does not display correctly or appears to contain an error, please email onar_upd.law@up.edu.ph with the issuance number on this page.
AI explanation
Summarize this issuance from the catalog record and the attached PDF.
Ask about this issuance
Questions are answered from this catalog record and the attached document. They are not legal advice.
Generated as a research aid. This is not a certified copy and is not an official legal interpretation by ONAR or the UP Law Center.
Publication information
Related issuances
Other published records from Food and Drug Administration.
Circulars Circular No. 2025-002
Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted during the 39th AESAEN Cosmetic Committee (ACC) Meeting and Its Related Meetings
Circulars FDA Circular No. 2025-001
Guidelines on the Classification of Vitamins and Minerals for Food/Dietary Supplements for Adults Under Processed Food Product, Repealing the Level Set for Food in the Office Order No. 22, s. 1991, Entitled "Guidelines for the Classification of Vitamins and Minerals as Drug or as Food"
Memorandum Circulars Memo Circular No. 2024-001
Validity of License to Operate (LTO) and Certificate of Product Registration (CPR) Granted to Veterinary Establishments and Drug Products for Livestock Feeds Transferred from Bureau of Animal Industry (BAI) to the Food and Drug Administration (FDA)
Circulars Circular No. 2024-005